Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vivos (RDGL) Research & Development (2017 - 2025)

Historic Research & Development for Vivos (RDGL) over the last 10 years, with Q3 2025 value amounting to $67820.0.

  • Vivos' Research & Development rose 190.68% to $67820.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $396035.0, marking a year-over-year decrease of 3960.78%. This contributed to the annual value of $324629.0 for FY2024, which is 5569.4% down from last year.
  • Vivos' Research & Development amounted to $67820.0 in Q3 2025, which was up 190.68% from $107965.0 recorded in Q2 2025.
  • Vivos' Research & Development's 5-year high stood at $432112.0 during Q4 2023, with a 5-year trough of $31736.0 in Q4 2022.
  • Over the past 5 years, Vivos' median Research & Development value was $72569.0 (recorded in 2022), while the average stood at $104423.4.
  • In the last 5 years, Vivos' Research & Development skyrocketed by 687470.82% in 2021 and then plummeted by 7663.36% in 2024.
  • Over the past 5 years, Vivos' Research & Development (Quarter) stood at $65694.0 in 2021, then crashed by 51.69% to $31736.0 in 2022, then surged by 1261.58% to $432112.0 in 2023, then tumbled by 76.63% to $100969.0 in 2024, then tumbled by 32.83% to $67820.0 in 2025.
  • Its last three reported values are $67820.0 in Q3 2025, $107965.0 for Q2 2025, and $119281.0 during Q1 2025.